Observational Study of Nanosecond Pulsed Field Ablation for Benign Thyroid Nodules
This observational study is looking at how well nanosecond pulsed field ablation (nsPFA) works to treat benign (non-cancerous) thyroid nodules. Researchers want to see how the size of the nodules changes over time and if this treatment improves your quality of life. They will also check for any complications. You might be able to join if you are between 18 and 80 years old, have a biopsy-confirmed benign thyroid nodule, and are already scheduled to receive nsPFA as part of your regular medical care. The study aims to enroll 30 participants, but its current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will watch what happens to 30 participants who are already receiving nsPFA. It is not a randomized trial.
- What's involved
- You would complete a patient-reported outcomes questionnaire. The study will observe your outcomes for an average of one year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for an average of one year to assess quality of life and other outcomes.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Victoria E Banuchi, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Quality-of-life QuestionnaireThrough study completion; an average of 1 year